Layer 1
Products 0

Refine

E.g., 25/02/2020
E.g., 25/02/2020

Refine

Refine

E.g., 25/02/2020
E.g., 25/02/2020

Products

Two strengths of the anti-acid ranitidine are among the most recent price concessions announced.
An initial 13 price concessions were announced on February 19. Among the latest concessionary prices are two strengths of the anti-acid ranitidine...
24/02/2020 0
Four of the five cities topping hand sanitiser demand are in coronavirus hotspots
The number of people buying hand sanitisers has risen 1,044% so far in February, when compared to the November-January period, online pharmacy Medino...
21/02/2020 1
People with phenylketonuria cannot break down the amino acid phenylalanine, which therefore “builds up in their blood and brain [and] can lead to...
20/02/2020 0
Drug Strength Form Price Co-careldopa 25mg/100mg tablets (100) £11.98 Fluoxetine 10mg capsules (30) £46.89 Frovatriptan 2.5mg tablets...
20/02/2020 0
Warwick Smith: The introduction of FMD has had a detrimental impact on manufacturing capability
Mr Smith expressed his disapproval of the anti-counterfeit medicines legislation during the annual Sigma conference in Cebu in the Philippines...
18/02/2020 6
Polypharmacy, when different medications are used by an individual at the same time, is becoming increasingly common because people are living for...
17/02/2020 1
Batch K84X of the Beconase Aqueous Nasal Spray from GSK has been recalled
Healthcare professionals and wholesalers have been told to immediately stop supplying batch K84X of the Beconase Aqueous Nasal Spray from...
13/02/2020 11
DH has asked companies to assess the possible impact of coronavirus on their business
Although there are no current medicine shortages in the UK linked to the coronavirus outbreak in China, the government is taking “precautionary...
13/02/2020 1
In this disposable world of cheap commodities, people often don’t return anything that stops working as it’s usually quicker and cheaper to simply...
11/02/2020 3
The BGMA welcomes government pledges to keep NHS “off the table” in trade negotiations
It is “critical” that the government resists any US proposals to “change patent or exclusivity provisions” that could delay the entry of generic and...
11/02/2020 0

Pages